The market for software development teams serving software companies is saturated, at least in Ann Arbor, where Alfa Jango founder Steve Schwartz has started and/or sold several startups himself alongside helping other new companies. That’s why he decided several years ago to focus on helping non-tech startups get the software development and guidance they would need so they could focus on the subject area they were expertise in. The results speak for themselves. Alfa Jango now serves clients that hail from YCombinator to Carnegie Mellon to the University of Michigan, and after selling startup Carcode to Edmunds in 2014 with a co-founder, Schwartz has now started another company called Genomenon on the side, which true to his vision uses his technical expertise on the tech side but focuses primarily on creating a genome interpretation software that empowers genomicists to compile and analyze research on immune disorders and cancer to better serve patients–rather than worrying about the software that allows them to do their work. Genomenon helps companies develop therapies or precision medicine to treat root causes of disease instead of symptoms, or build their knowledge database.